WebSome of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. WebUne partie des informations de ce site Web à été fournie par des sources externes. Le gouvernement du Canada n'assume aucune responsabilité concernant la précision, l'actualité ou la fiabilité des informations fournies par les sources externes.
Sommaire du brevet 2935013 - Base de données sur les brevets …
WebSep 14, 2024 · Xanthones are secondary metabolites found in plants, fungi, lichens, and … WebThe present invention relates to highly stable drug dosage forms comprising. The invention also contemplates said highly stable drug dosage forms for the treatment of diseases where inhibition of 4-hydroxyphenylpyruvate dioxygenase … pyke ost
Enantioselective Access to Tetrahydroxanthones via Copper-bis ...
WebThe present invention relates to highly stable drug dosage forms comprising. The invention also contemplates said highly stable drug dosage forms for the treatment of diseases where inhibition of 4-hydroxyphenylpyruvate dioxygenase … WebTwo tetrahydroxanthones, 1,3,5S,8S-tetrahydroxy-5,6,7,8-tetrahydroxanthone (1) and … WebA stable solid pharmaceutical formulation containing 2- (2-nitro-4-trifluoromethylbenzoyl) -1,3-cyclohexanedione as a pharmaceutically active ingredient, pregelatinized starch and stearic acid. pyke s11 supp